(Q37864925)

24 August 2017

1 reference

title

Progress and prospects: hurdles to cardiovascular gene therapy clinical trials (English)

1 reference

24 August 2017

0 references

1 reference

3

1 reference

24 August 2017

M Hedman

1

1 reference

24 August 2017

J Hartikainen

series ordinal

2

1 reference

24 August 2017

publication date

14 April 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

18

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

743-749

1 reference

Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Current status of cardiovascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Hotline sessions presented at the American College of Cardiology Congress 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Safety profile of plasmid/liposomes and virus vectors in clinical gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

VEGF inhibition: insights from preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

The potential of oligonucleotides for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Improved vascular gene transfer with a helper-dependent adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Capsid-Incorporation of Antigens into Adenovirus Capsid Proteins for a Vaccine Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

7 January 2021

Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

7 January 2021

Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

7 January 2021

Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

7 January 2021

Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

7 January 2021

In vivo gene transfer into muscle via electro-sonoporation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.43

7 January 2021

Identifiers

DOI

10.1038/GT.2011.43

1 reference

24 August 2017

1 reference